Back to search results

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Phoenix Children's Hospital, Phoenix, Arizona, United States

    Contact: Study coordinator (Chris Oless, RN) · coless@phoenixchildrens.com · 602-933-0920
    Contact: Principal Investigator (Laura Retson, DO)

  • Arkansas Children's Hospital, Little Rock, Arkansas, United States

    Contact: Study coordinator (Kevin Bielamowicz, MD) · kjbielamowicz2@uams.edu · 501-364-4405
    Contact: Principal Investigator (Kevin J Bielamowicz, MD)

  • City of Hope, Duarte, California, United States

    Contact: Study coordinator (Lindsey Murphy, MD) · lmurphy@coh.org · 626-218-0948
    Contact: Principal Investigator (Lindsey Murphy, MD)

  • Stanford University, Stanford, California, United States

    Contact: Study coordinator (Ankita Amberkar, BS) · ankitaamberkar@stanford.edu · (650)391-5318
    Contact: Principal Investigator (Norman Lacayo)
    Tanja Gruber (Sub-investigator)

  • Cincinnati Children's Hospital, Cincinnati, Ohio, United States

    Contact: Study coordinator (Jennifer Kamens, MD) · jennifer.kamens@cchmc.org · 215-589-8456
    Contact: Principal Investigator (Jennifer Kamens, MD)

  • Pennsylvania State University Hershey Medical Center, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Valerie Brown, MD, PhD) · vbrown1@hmc.psu.edu · 717-531-6012
    Contact: Principal Investigator (Valerie Brown, MD, PhD)

  • St. Jude Children's Research Hospital, Memphis, Tennessee, United States

    Contact: Study coordinator (Seth Karol, MD) · seth.karol@STJUDE.org · 901-595-1617
    Contact: Principal Investigator (Seth Karol, MD)

  • University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Spencer Mangum, MD) · Spencer.Mangum@hsc.utah.edu · 801-662-4700
    Contact: Principal Investigator (Spencer Mangum, MD)

  • University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Pediatric HemOnc Main Line) · PedsHemOncResearch@g-groups.wisc.edu · 608-263-6200
    Contact: Study coordinator (Cancer Connect) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Rebecca Richards, MD)
Study leads

  • Norman Lacayo, MD

    Principal Investigator

    Stanford Universiy

View source on ClinicalTrials.gov(opens in a new tab)